You are here

Novo Nordisk

Novo Nordisk chief Sørensen tops world's-best CEO ranking

Fierce Pharma

Tue, 10/13/15 - 06:12 pm

Why Novo Nordisk Is All in on New Diabetes Drug

TheStreet.com

Thu, 10/1/15 - 09:07 am

Novo Nordisk: Has This Company Solved The Anti-Obesity Sector Woes?

Seeking Alpha

Tue, 09/29/15 - 08:58 am

Novo combats talk of insulin price war with 'moderate premium' on brand-new Tresiba

Fierce Pharma

Mon, 09/28/15 - 06:13 pm

Novo scores a game-changing diabetes approval, reversing an embarrassing rejection

Fierce Biotech

Sat, 09/26/15 - 09:44 am

Novo's weekly diabetes drug clears another Phase III hurdle

Fierce Biotech

Fri, 09/25/15 - 08:45 pm

Novo Nordisk strikes deal with Iran government to produce insulin pens in the country

Fierce Pharma

Tue, 09/22/15 - 12:15 pm

drug manufacturing

Lilly's Heart Study Sets Up Showdown With Novo's Victoza

Bloomberg

Fri, 09/18/15 - 09:36 pm

Boehringer Ingelheim

Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal

Fierce Pharma

Wed, 09/16/15 - 06:01 pm

Novo Nordisk tops total returns of big European pharma firms

Bloomberg

Wed, 09/16/15 - 08:47 am

Analysts bet Novo's insulin drug will get U.S. green light

Yahoo/Reuters

Tue, 09/15/15 - 11:34 am

Novo Nordisk Launches Obesity Medication In Canada - How Did That Happen?

Seeking Alpha

Mon, 09/14/15 - 10:55 am

Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?

Fierce Pharma

Fri, 08/28/15 - 05:44 pm

Novo Nordisk buys diabetes startups founded by Lilly R&D veteran

Fierce Biotech

Fri, 08/28/15 - 09:51 am

Novo jumping into phase III trials for major oral diabetes candidate

BioPharma Dive

Thu, 08/27/15 - 11:36 am

Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion

Bizjournals.com

Wed, 08/26/15 - 08:45 pm

Novo pulls blockbuster diabetes med Victoza off the Type 1 track

Fierce Pharma Marketing

Wed, 08/26/15 - 10:41 am

type 1 diabetes

Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1

Fierce Pharma

Sat, 08/22/15 - 08:48 am

Will pricey new drug classes take the wind out of diabetes launches?

Fierce Pharma Marketing

Wed, 08/19/15 - 10:01 am

Boehringer Ingelheim

Novo Nordisk ties the R&D knot with Genmab, and they're not focused on cancer

Fierce Biotech

Fri, 08/14/15 - 11:20 am

Pages